Revenue (Tables)

12 Months Ended

Dec. 31, 2022

Disaggregation Of Revenue [Abstract]

Summary of information about disaggregated revenue in continuing operations

The following table provides information about disaggregated revenue (in thousands) recognized in continuing operations:

	2022		2021
License revenue:
Mayne Pharma	$	68,561	$	-
Theramex		1,402		2,573
Total revenue, net	$	69,963	$	2,573